APhA-ASP supports federal legislation that monitors and regulates the sale of pseudoephedrine-containing or other drug products used in the unlawful manufacture of methamphetamine or other illegal substances with the potential for abuse. Background Statement: Methamphetamine is a powerful and addictive CNS stimulant that is increasingly being illegally manufactured and abused in the United States. Use of methamphetamine is continually growing in the US, as evidenced by federal legislation passed 1996 (Comprehensive Methamphetamine Control Act) and in 2000 (Methamphetamine Anti-Proliferation Act). Over the last four years, there have been over 31,000 methamphetamine production operations seized in the United States by the Drug Enforcement Administration. Methamphetamine is manufactured using pseudoephedrine, a drug commonly found in OTC products. Because pseudoephedrine is easily accessible, it is imperative that federal legislation be enacted to uniformly and effectively monitor and regulate the sale of these products. By monitoring and regulating the sale of OTC products containing pseudoephedrine, we can help to reduce the amount of methamphetamine produced and identify individuals who may be manufacturing methamphetamine. The creation of a uniform federal system would enable state governments to effectively prevent the exploitation of any disparities in the system. While the Resolutions Committee feels that this issue is time sensitive, we would like to expand the policy so that it may be utilized to prevent the future illegal manufacturing of illicit substances using OTC drug products.